An illustration of the future of precision medicine and informed selection of IBD therapy. (IMAGE)

First Hospital of Jilin University

An illustration of the future of precision medicine and informed selection of IBD therapy.

Caption

In this approach, patients are assessed using a combination of clinical and molecular profiling, incorporating genetic, immunological and microbial evaluation. Complex raw data are interpreted by omics-based network medicine, allowing accurate molecular profiling of patient groups and informed selection of a therapeutic agent, combination therapy, observation or novel dietary or microbial interventions. Created with BioRender.com. IBD, inflammatory bowel disease.

Credit

By Little RD, Jayawardana T, Koentgen S, et al.

Usage Restrictions

Credit must be given to the creator.

License

CC BY

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.